Graeme Brookes

Amministratore Delegato presso Reapplix A/S

Health Technology

Distribution Services

Profilo

Graeme Brookes is currently the Chief Executive Officer at Reapplix A since 2014.
Prior to this, he was the Chief Executive Officer at The Acrobot Co. Ltd.

Posizioni attive di Graeme Brookes

Società	Posizione	Inizio
Reapplix A/S Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.	Amministratore Delegato	12/09/2014

Tutte le posizioni attive di Graeme Brookes

Precedenti posizioni note di Graeme Brookes

Società	Posizione	Fine
The Acrobot Co. Ltd. The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB.	Presidente	06/12/2012

Vedi nel dettaglio l'esperienza di Graeme Brookes

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Graeme Brookes

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
The Acrobot Co. Ltd. The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB.	Health Technology
Reapplix A/S Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.	Distribution Services